NC Public Health Division Addresses Synthetic Opioids and Ebola Outbreak in Congo

A microscopic view of the ebola virus.

The state’s Division of Public Health recently issued clinician memoranda regarding life threatening coagulopathy problems associated with the use of synthetic cannabinoids and the outbreak of the Ebola virus disease (EVD) in the Democratic Republic of Congo.

Coagulopathy Problems Associated with Synthetic Cannabinoid Use

This Provider Memo and CDC Health Advisory contain background information and recommendations regarding life threatening coagulopathy problems associated with the use of synthetic cannabinoids.

For more information on this please review the following CDC websites:

If you have any questions, please contact the Office of Environmental Epidemiology at 919-695-2662.

Ebola Virus Disease

The US Centers for Disease Control and Prevention (CDC) is advising health care providers in the United States to continue to obtain a travel history from all patients seeking care. Clinicians should promptly isolate patients that have symptoms compatible with EVD and a recent (within 21 days) history of travel to the affected areas in the Equateur Province of DRC, pending diagnostic testing. Providers should also consider other infectious disease risks that are much more common in returning travelers, including malaria.

If any of your patients meet these criteria please call the Communicable Disease branch for assistance at 919-733-3419. Additional information is available here.


Share this Post


Leave a Reply

The NCMS moderates this blog, so expect a slight delay in posting. Please include your full name and affiliation. We insist on respectful dialogue and reserve the right not to post remarks incompatible with our guidelines.

Your email address will not be published. Required fields are marked *